Industry Comparables

OTC: CLCS

Stock Information

SHARE PRICE: $0.28

VOLUME: 6,819

MARKET CAP: $12,171,096.00

SHARE COUNT: 43,468,200

DAILY HIGH: $0.28

DAILY LOW: $0.26

OPEN: $0.26

CLOSE: $0.29

PREV. CLOSE: $0.29

CHANGE: $0.01 (-3.4482727%)

52-WEEK HIGH: $0.8401

52-WEEK LOW: $0.0002

LAST UPDATED: 13 hours ago

CompanySymbolMarketcapPriceExchangeChart (24H)
Cell Source, Inc.CLCS12.17M$0.28OQB
CompanySymbolMarketcapPriceExchangeChart (24H)
Allogene Therapeutics, Inc.ALLO347.62M$1.60NMS
Atara Biotherapeutics, Inc.ATRA40.54M$6.92NMS
bluebird bio, Inc.BLUE37.50M$3.85NMS
Fate Therapeutics, Inc.FATE103.45M$0.9027NGM
KDMN0.0000$0.0000
Legend Biotech CorporationLEGN6.44B$35.05NMS

Investor Presentation

Investor Relations Contact

Cell Source, Inc.
57 West 57th Street, Suite 400
New York, NY 10019

Phone: 646-612-7554
Toll Free: 888-315-4650
Email: info@cell-source.com

Securities Counsel

Giordano Halleran & Ciesla
Philip D. Forlenza, Esq.
125 Half Mile Road, Suite 300
Red Bank, NJ 07701-6777

Phone: 732-741-3900
Email: PForlenza@ghclaw.com
WWW: www.ghclaw.com

Independent Auditor

Marcum LLP
750 Third Ave, 11th Floor
New York, NY 10017

Additional Information

Subscribe to Cell Source’s Newsletter

    INVESTOR ALERTS. PRESS RELEASES. INDUSTRY & COMPANY NEWS.

    Get the latest Cell Source news and updates, delivered right to your inbox.